Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Iradimed (IRMD) Assets Average (2016 - 2025)

Historic Assets Average for Iradimed (IRMD) over the last 12 years, with Q3 2025 value amounting to $110.6 million.

  • Iradimed's Assets Average rose 2007.27% to $110.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $110.6 million, marking a year-over-year increase of 2007.27%. This contributed to the annual value of $95.2 million for FY2024, which is 721.11% up from last year.
  • Per Iradimed's latest filing, its Assets Average stood at $110.6 million for Q3 2025, which was up 2007.27% from $104.1 million recorded in Q2 2025.
  • In the past 5 years, Iradimed's Assets Average registered a high of $110.6 million during Q3 2025, and its lowest value of $71.6 million during Q1 2021.
  • Its 5-year average for Assets Average is $85.8 million, with a median of $82.5 million in 2022.
  • Its Assets Average has fluctuated over the past 5 years, first grew by 23.61% in 2022, then soared by 2007.27% in 2025.
  • Quarter analysis of 5 years shows Iradimed's Assets Average stood at $80.6 million in 2021, then rose by 2.34% to $82.5 million in 2022, then increased by 8.79% to $89.8 million in 2023, then rose by 7.25% to $96.3 million in 2024, then grew by 14.85% to $110.6 million in 2025.
  • Its Assets Average stands at $110.6 million for Q3 2025, versus $104.1 million for Q2 2025 and $100.0 million for Q1 2025.